EZ BIOPAC®

Proven to Reduce Fill Time and Cross Contamination

  • EZ BioPac®, ILC Dover’s purpose-built powder containment and transfer system, speeds fill time and makes it easy to adjust contents to precise target weight
  • It’s separate discharge outlet and antistatic polymer material mean faster, cleaner discharge with residuals consistently 2g or less in a 5 kg bag
  • The EZ BioPac® bag’s unique design and protective skirt reduce or eliminate contamination of the support stand and bag exterior, drastically reducing clean-up requirements

Download Whitepaper

BENEFITS

Ease To Use

EZ BioPac® bags and custom polypropylene support stand allow fast, foolproof set-up

Reduce Fill Time

Large-diameter top opening speeds filling by as much as 71%

Minimize Cleaning

Attached zip ties or ILC Dover’s proprietary crimping system assure complete closure and containment of the bag’s contents

Wide Capacity Range

Bags are available in capacities from 1 to 100 liters to suit full range of plant requirements

Array of Flange Sizes

EZ BioPac® bags offer discharge sanitary flange sizes from 1.5˝ to 8˝ to match a variety of process vessels

EZ BIOPAC®

Issues Of Powder Handling

Media and buffer ingredients used in powder form have historically been transferred from stock containers using open scoops, funnels and bags, then carried and dumped directly into production vessels, since sterility wasn’t required at that early manufacturing stage. While sterility may not be an issue, biopharmaceutical production managers have come to recognize that worker exposure to airborne particulates and the potential for cross-contamination at line change-over can be.


Consequently, they have started to implement single-use systems for powder transfer. Unfortunately, many early systems were simply adapted from liquid-handling systems already in use at the time, and converted to handle powders. These systems often have inherent shortcomings. Instead, production managers should look for systems designed from the ground up to handle biopharmaceutical powders.

Download Brochure

Boosting Profitability With Single-Use Powder Transfer

Many biopharmaceutical manufacturers are implementing single-use containment for transfer of media and buffer materials to prevent feedstock contamination and to promote worker safety. The type of containment system used, however, can have a significant impact on productivity and profitability. Equipment should be evaluated and chosen carefully.

Download Poster

The Keys To Efficient Powder Transfer And Containment

The most efficient powder containment and transfer equipment will feature:

  • A design developed specifically to handle powders
  • Fast filling
  • Easy, complete sealing
  • Fast, clean dispensing
  • Complete product recovery (i.e., no powder left in the container)
  • Self-supporting containers to promote easy handling and distribution


Unlike systems adapted from an existing liquid-handling system,  ILC Dover’s EZ BioPac® system was designed specifically to handle powders in biopharmaceutical applications. The EZ BioPac® system from ILC Dover substantially lessens the amount of powder that disperses into the air, reduces the time needed for changeover, lowers staff costs, and frees staff to work on more vital jobs, which all contribute to profitability.

Contact Local Containment Expert

Tel:  1 (302) 335-3911

Fax: 1 (302) 335-0762

Web:www.ilcdover.com

Go to article: Home | Mapping the MindGo to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: EditorialGo to article: Biocorp Company InsightGo to article: BiocorpGo to article: ContentsGo to article: Fisher Clinical ServicesGo to article: Malvern Panalytical Company InsightGo to article: Malvern PanalyticalGo to article: NewsGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The Pharma Industry BriefingGo to article: Mattler ToledoGo to article: MedelpharmGo to article: HPV vaccines: a decade of progressGo to article: Nipro PharmaPackagingGo to article: PfanstiehlGo to article: Hereditary Alzheimer’s: could rare genes hold the clue to a cure?Go to article: SGSGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: Could a unique brain fingerprint predict a drug’s effectiveness?Go to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Genetic studies: a powerful tool for testing combination therapiesGo to article: Nelson Lab Company InsightGo to article: Nelson LabGo to article: Abiogen PharmaGo to article: The Express Scripts story; super-pharmacies and the US drug industryGo to article: B Medical SystemsGo to article: Daiichi JitsugyoGo to article: LaudaGo to article: Is a lack of female participants skewing heart disease trial results?Go to article: EcocoolGo to article: HOF SonderanlagenbauGo to article: DiverseyGo to article: Why the German Centre for Diabetes Research changed its approach to handling dataGo to article: Dow Europe GmbH Company InsightGo to article: Dow Europe GmbHGo to article: QualiMetriXGo to article: How digital innovation is helping to drive transformation in regulatory affairs Go to article: DryceGo to article: ILC Dover IncGo to article: Pall BiotechGo to article: EventsGo to article: Event: Pharmpack EuropeGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: Unither PharmaceuticalsGo to article: Next issueGo to article: ButterworthGo to article: myLiquitab